Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Aimin Pharmaceutical is a Chinese pharmaceutical company headquartered in Meizhou, Guangdong Province, specializing in the development and manufacturing of chemical pharmaceuticals. Founded in 1998, the company has established a strong presence in the domestic market with a focus on metabolic, cardiovascular, and respiratory therapeutic areas. Its product portfolio features a range of essential medicines, including L-carnitine oral solutions, diabetes treatments like Metformin and Gliclazide, and over-the-counter cold remedies. Aimin operates state-of-the-art GMP-certified facilities and is recognized as a key high-tech enterprise within the regional healthcare sector. The company emphasizes quality control and technological innovation to provide affordable and effective healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Aimin Pharmaceutical.